Association between 3D membranous urethral parameters and urinary continence recovery after RARP

Table 3 Univariate and multivariate regression analysis of patients achieving continence 3 months after RARP and those who cannot

	Total	Patients achieving continence 3 month after RARP group		Patients failed to achieve continence 3 month after RARP group		P	Multivariate
	Total	Patients achieving continence 3 month after RARP group					OR	95%CI	P
No. patients (%)	120	101 (84.17)		19 (15.83)
		Mean	SD	Mean	SD
Age (years)		68.76	5.60	72.11	5.54	0.018	0.904	0.818–0.998	0.046
BMI (kg/m²)		23.29	2.52	23.92	3.04	0.337
tMUV (mm³)		1389.58	438.90	1150.17	584.66	0.029	1.000	0.998–1.002	0.981
eMUV (mm³)		898.76	272.72	727.20	324.23	0.016	1.002	1.000–1.004	0.042
fMUL (mm)		18.89	2.59	17.61	2.63	0.051
eMUL (mm)		13.06	2.20	12.06	1.47	0.060
PV (cc)		36.52	24.23	33.37	20.70	0.570
VPSS		9.57	0.42	11.53	0.96	0.058

The statistically significant p values in the table are shown in bold
BMI body mass index, OR odd ratio, CI confidence interval, SD standard deviation, tMUV total membranous urethral complex volume, eMUV exposed membranous urethral complex volume, fMUL full membranous urethral length, eMUL exposed membranous urethral length, PV prostate volume, VPSS visual prostate symptom score

ISSN: 2047-783X